Solution
Industries
Resources
About
Beacon Search

Aethlon Medical Inc.

Company Snapshot

Founded: 1999
Entity Type: Public
Employees: 14
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S.
Corporate Address: 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121 U.S. Tel. +1-619-941-0360 www.aethlonmedical.com

Company Overview

Aethlon Medical, Inc. is a medical therapeutic company focused on developing products for cancer and deadly infectious disease treatment. Its lead therapeutic candidate is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device designed to treat cancer and fatal viral infections.

In cancer, the Hemopurifier is designed to eliminate the presence of circulating tumor (CT)-derived exosomes that facilitate immune suppression, seed the spread of metastasis, and prevent the benefit of leading cancer therapies.

On September 12, 2019, the NCI awarded Aethlon Medical a Small Business Innovation Research Program (SBIR) Phase II Award Contract for NIH/NCI Topic 359, entitled “A Device Prototype for Isolation of Melanoma Exosomes for Diagnostics and Treatment Monitoring.” The Award Contract amount was $1.9 million and, as amended, ran from September 16, 2019, through September 15, 2022.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Aethlon Medical Inc. In Reports

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

BCC Research Market Report provides an overview of Exosome Diagnostics and Therapeutics Market scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028).

OTC Drugs, Medical Devices and Diagnostics: Global Markets

Get an overview of the global markets for over-the-counter (OTC) drugs, medical devices and diagnostics. Analyses of global market trends with data from 2018 to 2019, and projections of compound annual growth rates...

Medical Membrane Devices: Markets and Technologies

The global market for medical membrane devices should grow from $28.6 billion in 2018 to $36.5 billion by 2023 at a compound annual growth ratebof 5.0% for the period of 2018-2023.

View All Reports

Applications/End User Industries

  • Infectious Diseases
  • Healthcare
  • Pharmaceutical
  • Oncology
  • Biotechnology
  • Immunotherapeutic
  • Cancer Disease
  • Metastatic Cancer
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment